Immuneering
IMRX
NASDAQ
IPO2021
about IMRX
Immuneering is a biopharmaceutical company focused on developing innovative treatments, with a pipeline that includes products targeting cancer immunotherapy and rare diseases, utilizing cutting-edge technology to advance drug discovery and development.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $4.68 | $4.92 | $4.20 | $305.42M | 3.66M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.38 | n/a | n/a | 0% | 0% | 0% |